Jason Cohen, Editor

About the Author Jason Cohen, Editor


Mizuho Sets Expectations on Valeant (VRX) Ahead of Earnings

Valeant (NYSE:VRX) is raring to deliver what Mizuho’s Irina Rivkind Koffler expects will be a solid …

Here’s Why You Shouldn’t Get Too Excited About AcelRx Pharmaceuticals (ACRX) Stock

Not everyone is excited about AcelRx Pharmaceuticals (NASDAQ:ACRX), which focused on the development and commercialization of …

AcelRx (ACRX): Shoring up the Balance Sheet by Selling Stock Comes with a Price

Shares of drug maker AcelRx Pharmaceuticals (NASDAQ:ACRX) slumped on Thursday, falling 13% as of 10:34 a.m. …

Why Galmed Pharmaceuticals (GLMD) Is a $59 Stock

Galmed Pharmaceuticals (NASDAQ:GLMD) shares are soaring nearly 20% in after-hours trading Wednesday, as the drug …

Arrowhead Research (ARWR): ARO-AAT Data Provides Early Clinical Validation, Says Analyst

Shares of drug maker Arrowhead Research (NASDAQ:ARWR) rose nearly 9% today on heavy volume, thanks …

Senseonics (SENS) Bull Lowers Price Target Post Recent Financing

Shares of medical technology firm Senseonics (NYSE American:SENS) dipped nearly 12% last week, following the …

Adamis Pharma (ADMP) Stock: Next Stop, $7.50?

It’s a big day for Adamis Pharma (NASDAQ:ADMP). The drug maker announced a commercial partnership for …

Why Adamis (ADMP) Is Skyrocketing Today

Adamis Pharmaceuticals (NASDAQ:ADMP) is a mover and shaker out on the Street today, with investors …

Tesla (TSLA): Do You Feel the Electricity, Too?

Tesla (NASDAQ:TSLA) investors have a smile on their faces Monday morning, following the news that the …

Rally on! Here’s Why Gemphire Therapeutics (GEMP) Stock Has Another 222% to Go

It’s a very rewarding trading day for investors in Gemphire Therapeutics (NASDAQ:GEMP) with shares up …